Please assess the completion status of the following clinical trial:

Trial Title: Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult trauma patients admitted to the emergency department at the University of Alabama at Birmingham (UAB) Hospital~* Blunt or penetrating injury~* UAB highest trauma activation~Exclusion Criteria:~* Age \< 19 years of age~* Patients with known bleeding diathesis or who are concurrently taking anticoagulant medication~* Patients with known liver disease~* Minor patients~* Pregnant patients (known or suspected pregnancy)~* Patients who are incarcerated~* Patients who lack a surrogate

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vitamins C and E (Type: EXPERIMENTAL): Vitamin C (1,000 mg i.v.) and Vitamin E (1,000 IU p.o. via the naso-gastric tube) administered every 8 hours starting within one hour after admission to the Emergency department for up to 5 days or until discharge from the ICU, whichever comes first.
- 0.9% saline and sugar pill (Type: PLACEBO_COMPARATOR): 100 ml of 0.9% saline (for i.v. Vitamin C) and a p.o. placebo (sugar pill for the p.o. Vitamin E) administered every 8 hours starting within one hour after admission to the Emergency department for up to 5 days or until discharge from the ICU, whichever comes first.

Based on this trial design, predict the completion outcome and termination type (if applicable).